Andrew Allen

Andrew Allen

Company: Gritstone Oncology

Job title: CEO


Using Normal Immune Responses as the Engine for Cancer Immunotherapy 8:45 am

• Antigen selection – define the power of neoantigens • Antigen delivery – setting immunologic goals and choosing the right vectors for humans • Are we meeting the goal(s) and seeing clinical efficacy?Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.